Autoimmunity & Inflammation
The human immune system protects us against harmful stimuli such as pathogens, toxic cellular components and cancer. However, because of various factors the immune system can become dysregulated, overactive and harmful itself. Excessive and harmful inflammation can occur during autoimmune diseases, auto-inflammatory disorders, allergies, organ transplantation, and also plays an important role in neurological disorders such as Alzheimer’s Disease and Multiple Sclerosis. Because of the complexity of these disorders most of the currently used treatments target the immune system in general.
The TechTalk ‘Autoimmunity and inflammation’ gives an overview of fundamental research and drug development for several inflammatory disorders in and around the Leiden Bio Science Park.
Wendy Zacouris-Verweij (NVLE - Nationale vereniging voor LUPUS, APS, Sclerodermie en MCTD: Unmet needs for patients
- Innate Immunity as a therapeutic target in kidney transplantation
Prof.Dr. Cees van Kooten, Department of Nephrology, LUMC
- The development of drugs for the treatment of autoimmune diseases
Dhr. Jan Stallen, Galapagos
- T helper 17.1 cells as selective contributors to early multiple sclerosis
Dr. Marvin van Luijn, Department of Immunology, Erasmus MC
- Dr. Ulrich Scherer, Department of Rheumatology, LUMC: The B cell response in the development of rheumatoid arthritis
Thursday, June 7, 15.15 - 17.00 hrs.
You are welcome to walk-in from 15.15 hrs, the program starts at 15.30 hrs.
De Stal, Darwinweg 1, 2333 CR Leiden
The R&D community of Leiden Bio Science Park and others interested.
TechTalks are aimed at bringing the research community together across Leiden Bio Science Park, whether based in business or in academia, and others who are interested.
Luris, Leiden Bio Science Park, Boerhaave Nascholing and Centrum Bioscience en Diagnostiek